Xeris Biopharma Holdings (XERS) Return on Assets [ROA] (2021 - 2026)
Xeris Biopharma Holdings (XERS) posted Return on Assets [ROA] of -4.27% for Q2 2026, up 5.57 percentage points from -9.84% a year earlier but down 7.37 percentage points from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, Xeris Biopharma Holdings' Return on Assets [ROA] came in at 0.16%, up 17.14 percentage points from FY2024.
- Annual Return on Assets [ROA] has increased for four consecutive years, with a four-year change of +53.11 percentage points (FY2021 to FY2025).
- In prior years, Xeris Biopharma Holdings' Return on Assets [ROA] was -16.99% in FY2024 (+1.68 pp), -18.66% in FY2023 (+10.51 pp), -29.18% in FY2022 (+23.78 pp) and -52.95% in FY2021.
- Quarterly Return on Assets [ROA] has run from a low of -56.34% in Q4 2021 to a high of 3.10% in Q1 2026 over five years.
- On a year-over-year basis, Return on Assets [ROA] has increased in each of the last seven quarters, with an average year-over-year change of +8.73 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2022, with a gain of 27.11 percentage points; the weakest was Q3 2024, with a drop of 0.51 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 3.10% (Q1 2026), 0.15% (Q4 2025) and -4.44% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.14% |
| 10 | Xeris Biopharma Holdings | 1.61 Bn | 1.17 Bn | 79.59 Mn | -4.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.27% |
| Mar 31, 2026 | 3.10% |
| Dec 31, 2025 | 0.15% |
| Sep 30, 2025 | -4.44% |
| Jun 30, 2025 | -9.84% |
| Mar 31, 2025 | -14.12% |
| Dec 31, 2024 | -17.03% |
| Sep 30, 2024 | -19.33% |
| Jun 30, 2024 | -17.82% |
| Mar 31, 2024 | -19.54% |
| Dec 31, 2023 | -19.14% |
| Sep 30, 2023 | -18.82% |
| Jun 30, 2023 | -21.98% |
| Mar 31, 2023 | -23.36% |
| Dec 31, 2022 | -29.24% |
| Sep 30, 2022 | -42.64% |
| Jun 30, 2022 | -41.66% |
| Mar 31, 2022 | -43.00% |
| Dec 31, 2021 | -56.34% |
API Access
Xeris Biopharma Holdings Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();